Calendrier des promotions Intensity Therapeutics, Inc.
Calendrier avancé
Graphique simple
À propos de l'entreprise Intensity Therapeutics, Inc.
Intensity Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of cancer drugs to treat solid tumors. Its lead product candidate includes INT230-6, a clinical trial for the treatment of refractory solid tumors and pancreatic, colon, bile duct, squamous cell carcinoma, sarcoma, breast, and liver cancers. The company was incorporated in 2012 and is headquartered in Westport, Connecticut.Paramètres de base
IPO date
2023-06-30
ISIN
US45828J1034
Industry
Biotechnology
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Сайт
Grade
Sous-estimation
| Nom | Signification | Grade |
| P/S | 0 | 0 |
| P/BV | 8.39 | 1 |
| P/E | 0 | 0 |
Efficacité
| Nom | Signification | Grade |
| ROA | -147.37 | 0 |
| ROE | -202.34 | 0 |
| ROIC | 0 | 0 |
Dividendes
| Nom | Signification | Grade |
| Rendement en dividendes | 0 | 0 |
| DSI | 0 | 0 |
| Croissance moyenne du dividende | 0 | 0 |
Devoir
| Nom | Signification | Grade |
| Debt/EBITDA | -0.0083 | 10 |
| Debt/Ratio | 0.0289 | 10 |
| Debt/Equity | 0.6391 | 9 |
Impulsion de croissance
| Nom | Signification | Grade |
| Rentabilité Revenue, % | 0 | 0 |
| Rentabilité Ebitda, % | 167.5 | 10 |
| Rentabilité EPS, % | 258.72 | 10 |
paper.price.prices
| Prix | Common.min. | Common.max. | Changement | paper.changes_in_industry | paper.changes_in_index | |
| common.calendar.number_days.1 | 0.3229 $ | 0 $ | 0 $ | 0 % | 0 % | 0 % |
| common.calendar.number_days.7d | 0.375 $ | 0 $ | 0 $ | -13.89 % | 0 % | 0 % |
| common.calendar.number_days.30d | 0.6369 $ | 0.3177 $ | 0.4148 $ | -49.3 % | 0 % | 0 % |
| common.calendar.number_days.90d | 2.2 $ | 0.3177 $ | 2.29 $ | -85.32 % | 0 % | 0 % |
| common.calendar.number_days.180d | 2.79 $ | 0.3177 $ | 2.77 $ | -88.42 % | 0 % | 0 % |
| common.calendar.number_days.1y | 4.84 $ | 0.3177 $ | 5.09 $ | -93.33 % | 0 % | 0 % |
| common.calendar.number_days.3y | 0 $ | 0.3177 $ | 9.88 $ | 0 % | 0 % | 0 % |
| common.calendar.number_days.5y | 0 $ | 0.3177 $ | 9.88 $ | 0 % | 0 % | 0 % |
| common.calendar.number_days.10y | 0 $ | 0.3177 $ | 9.88 $ | 0 % | 0 % | 0 % |
| common.calendar.number_days.ytd | 2.06 $ | 0.3177 $ | 2.77 $ | -84.33 % | 0 % | 0 % |
Principaux propriétaires
Entreprises similaires
P/E & P/BV
Gestion d'entreprise
| Superviseur | Titre d'emploi | Paiement | Année de naissance |
| Mr. Lewis H. Bender M.A., M.B.A., M.S. | Founder, President, CEO & Chairman of the Board | 1.1M | 1959 (66 années) |
| Mr. John Wesolowski CPA, M.B.A. | Principal Accounting Officer & Controller | 272.37k | 1960 (65 années) |
| Mr. James M. Ahlers | Executive Vice President of Corporate Finance | 75.09k | 1964 (61 année) |
| Mr. Brian Schwartz M.D. | Executive Vice President of Clinical Development | N/A | |
| Mr. Joseph Talamo CPA, M.B.A. | Chief Financial Officer | N/A | 1969 (56 années) |
Informations sur l'entreprise
Adresse: United States, Westport. CT, 61 Wilton Road - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: https://intensitytherapeutics.com
Site web: https://intensitytherapeutics.com
